Roche
ROG.SW
$274.16
Share price
0.30%
Change (1 day)
-17.36%
Change (1 year)
Categories
Revenue for Roche (ROG.SW)
Revenue in 2022: $68.50 B
According to Roche's latest financial reports the company's current revenue (TTM) is $68.50 B. In 2022 the company made a revenue of $68.50 B a decrease over the years 2021 revenue that were of $68.73 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Roche from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | $68.50 B | -0.34% |
| 2021 | $68.73 B | 3.89% |
| 2020 | $66.15 B | 4.26% |
| 2019 | $63.45 B | 9.8% |
| 2018 | $57.79 B | 5.58% |
| 2017 | $54.73 B | 10.25% |
| 2016 | $49.64 B | 1.88% |
| 2015 | $48.72 B | 1.49% |
| 2014 | $48.01 B | -8.94% |
| 2013 | $52.72 B | 5.76% |
| 2012 | $49.85 B | 9.97% |
| 2011 | $45.33 B | -10.75% |
| 2010 | $50.80 B | 7.11% |
| 2009 | $47.42 B | 8.43% |
| 2008 | $43.74 B | 7.33% |
| 2007 | $40.75 B | 17.93% |
| 2006 | $34.55 B | 28.04% |
| 2005 | $26.98 B | -1.58% |
| 2004 | $27.42 B | 8.61% |
| 2003 | $25.24 B | -23.76% |
| 2002 | $33.11 B | 1.93% |
| 2001 | $32.48 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.76 B | 36.88% | 🇺🇸 USA |
 Novartis NVS | $53.07 B | -22.52% | 🇨🇭 Switzerland |
 Pfizer PFE | $77.94 B | 13.79% | 🇺🇸 USA |
 Abbott Laboratories ABT | $40.22 B | -41.28% | 🇺🇸 USA |
 Amgen AMGN | $26.58 B | -61.19% | 🇺🇸 USA |
 Sanofi SNY | $48.63 B | -29.00% | 🇫🇷 France |
 Becton Dickinson BDX | $19.04 B | -72.20% | 🇺🇸 USA |
 Merck MRK | $58.31 B | -14.88% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $35.34 B | -48.40% | 🇬🇧 UK |